Loukia Parisiadou, Ph.D.

National Institutes of Health, Bethesda, MD 
"Loukia Parisiadou"
Mean distance: 17.56 (cluster 32)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Skelton PD, Tokars V, Parisiadou L. (2022) LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights. Cells. 11
Tayebi N, Parisiadou L, Berhe B, et al. (2017) Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course. Molecular Genetics and Metabolism. 122: 198-208
Liu G, Sgobio C, Gu X, et al. (2015) Selective Expression of Parkinson's disease-related Leucine-rich Repeat Kinase 2 G2019S Missense Mutation in Midbrain Dopaminergic Neurons Impairs Dopamine Release and Dopaminergic Gene Expression. Human Molecular Genetics
Cho HJ, Yu J, Xie C, et al. (2014) Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. The Embo Journal. 33: 2314-31
Luo J, Sun L, Lin X, et al. (2014) A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons. Human Molecular Genetics. 23: 6567-74
Parisiadou L, Yu J, Sgobio C, et al. (2014) LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nature Neuroscience. 17: 367-76
Tao R, Vassilopoulos A, Parisiadou L, et al. (2014) Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxidants & Redox Signaling. 20: 1646-54
Parisiadou L, Yu J, Sgobio C, et al. (2014) Erratum: Corrigendum: LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity Nature Neuroscience. 17: 1287-1287
Cho HJ, Liu G, Jin SM, et al. (2013) MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Human Molecular Genetics. 22: 608-20
Lin X, Parisiadou L, Sgobio C, et al. (2012) Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9248-64
See more...